Amanote Research
Register
Sign In
Figure 2: Cytotoxicity of Fractions Obtained From B. Fasciatus Venom by Gel-Filtration and Reversed Phase Chromatography Against Human McF7 and A549 Cell Lines.
doi 10.7717/peerj.8055/fig-2
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 4: Cytotoxicity Test of Fractions Obtained From B. Fasciatus Venom Against Normal Human Kidney HK2 Cells.
Figure 5: Cytotoxicity of Cisplatin to Human A549 (A), McF7 (B) and HK2 (C) Cell Lines.
Figure 3: MALDI Mass Spectroscopy Analysis of B. Fasciatus Venom Fractions.
Figure 1: Fractionation of B. Fasciatus Venom.
Figure 2: I-CRP Kills A549 and A427 NSCLC Cell Lines.
Figure S2: Total Protein Yield Obtained From (A) Demineralization Fractions, and (B) Solubilization Fractions
Separations by Reversed-Phase Chromatography
Figure 6: Morphological Changes of the A549 (A–B) and McF7 (D–F) Cells After Treatment With Fractions BF3 (B and E) or BF3.3 (C and F) for 72 H Detected by Phase Contrast Microscopy.
Phospholipase A2 From Krait Bungarus Fasciatus Venom Induces Human Cancer Cell Death in Vitro
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
